A Review of Regulatory Mechanisms Used by the WHO, EU, and US to Facilitate Access to Quality Medicinal Products in Developing Countries With Constrained Regulatory Capacities-Reference-Cited by-同舟云学术

A Review of Regulatory Mechanisms Used by the WHO, EU, and US to Facilitate Access to Quality Medicinal Products in Developing Countries With Constrained Regulatory Capacities

Published:2013-03 Issue:2 Volume:47 Page:268-276
ISSN:2168-4790
Container-title:Therapeutic Innovation & Regulatory Science
language:en
Short-container-title:Ther Innov Regul Sci

Author:

Saidu Yauba,De Angelis Dario,Aiolli Silvia,Gonnelli Stefano,Georges Anne Marie

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Public Health, Environmental and Occupational Health,Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

Link

http://link.springer.com/content/pdf/10.1177/2168479012474281.pdf

Reference55 articles.

1. World Health Organization (WHO). Effective Drug Regulation: What Can Countries Do? Geneva, Switzerland: WHO; 1999.

2. World Health Organization. WHO policy perspectives on medicines—effective medicines regulation: ensuring safety, efficacy and quality. 2003. http://whqlibdoc.who.int/hq/2003/WHO_EDM_2003.2.pdf. Accessed January 7, 2012.

3. World Health Organization (WHO). The Safety of Medicine in Public Health Programs: Pharmacovigiliance and Essential Tool. Geneva, Switzerland: WHO; 2006.

4. World Health Organization (WHO). World medicine situation. 2004. http://apps.who.int/medicinedocs/pdf/s6160e/s6160e.pdf. Accessed January 7, 2012.

5. McAuslane N, Cone M, Collins J. R&D Briefing No: a cross-regional comparison of the regulatory environment in emerging markets. 2005. http://213.120.141.158/sites/default/files/RD%2050%20Feb06%20EM%20Cross%20Regional%20Compar.pdf. Accessed November 7, 2011.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison between European Medicines Agency and US Food and Drug Administration in Granting Accelerated Marketing Authorizations for Covid-19 Medicines and their Utilized Regulations;Therapeutic Innovation & Regulatory Science;2023-10-20

2. A Proposed Framework for a Globally Applicable Pragmatic Approach to Using Facilitated Regulatory Pathways;Therapeutic Innovation & Regulatory Science;2020-01

3. A Proposed Framework for a Globally Applicable Pragmatic Approach to Using Facilitated Regulatory Pathways;Therapeutic Innovation & Regulatory Science;2018-12-06

4. Ebola viral disease in West Africa: a threat to global health, economy and political stability;Journal of Public Health in Africa;2016-08-17

5. Accelerating access to new medicines: Current status of facilitated regulatory pathways used by emerging regulatory authorities;Journal of Public Health Policy;2016-08